Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 341

1.

Dopaminergic neurons.

Chinta SJ, Andersen JK.

Int J Biochem Cell Biol. 2005 May;37(5):942-6. Epub 2004 Dec 2. Review.

PMID:
15743669
2.

Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice.

Hwang DY, Ardayfio P, Kang UJ, Semina EV, Kim KS.

Brain Res Mol Brain Res. 2003 Jun 10;114(2):123-31.

PMID:
12829322
3.

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

Damier P, Hirsch EC, Agid Y, Graybiel AM.

Brain. 1999 Aug;122 ( Pt 8):1437-48.

PMID:
10430830
4.

Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors.

Simon HH, Bhatt L, Gherbassi D, Sgadó P, Alberí L.

Ann N Y Acad Sci. 2003 Jun;991:36-47.

PMID:
12846972
5.

Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?

Damier P, Kastner A, Agid Y, Hirsch EC.

Neurology. 1996 May;46(5):1262-9.

PMID:
8628464
6.

Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.

Smits SM, van der Nobelen S, Hornman KJ, von Oerthel L, Burbach JP, Smidt MP.

Neuroscience. 2005;136(1):171-9. Epub 2005 Sep 28.

PMID:
16198487
7.
8.

Biochemistry of Parkinson's disease with special reference to the dopaminergic systems.

Hirsch EC.

Mol Neurobiol. 1994 Aug-Dec;9(1-3):135-42. Review.

PMID:
7888089
9.

Homeobox gene Pitx3 and its role in the development of dopamine neurons of the substantia nigra.

Smidt MP, Smits SM, Burbach JP.

Cell Tissue Res. 2004 Oct;318(1):35-43. Epub 2004 Aug 6. Review.

PMID:
15300495
10.

The role of Pitx3 in survival of midbrain dopaminergic neurons.

Smits SM, Smidt MP.

J Neural Transm Suppl. 2006;(70):57-60. Review.

PMID:
17017509
11.
12.

Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.

Testa CM, Sherer TB, Greenamyre JT.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):109-18. Epub 2005 Jan 6.

PMID:
15790535
14.
15.

Molecular mechanisms underlying midbrain dopamine neuron development and function.

Smidt MP, Smits SM, Burbach JP.

Eur J Pharmacol. 2003 Nov 7;480(1-3):75-88. Review.

PMID:
14623352
16.

Pathogenesis of Parkinson's disease.

Schapira AH.

Baillieres Clin Neurol. 1997 Apr;6(1):15-36. Review.

PMID:
9426866
17.

New face of neuromelanin.

Double KL, Halliday GM.

J Neural Transm Suppl. 2006;(70):119-23. Review.

PMID:
17017518
18.

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y.

Histol Histopathol. 1997 Jan;12(1):25-31.

PMID:
9046040
19.

Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.

Perier C, Bender A, García-Arumí E, Melià MJ, Bové J, Laub C, Klopstock T, Elstner M, Mounsey RB, Teismann P, Prolla T, Andreu AL, Vila M.

Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196.

PMID:
23884809
20.

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y.

J Neurochem. 1992 Sep;59(3):1080-9.

PMID:
1494900

Supplemental Content

Support Center